Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash on Interstate 15 at Bundy Canyon Road


SUV Crashes Into Embankment in Fatal Wildomar Accident

accidentnews5

Wildomar, CA (March 10, 2020) – One person was killed in a crash in Wildomar. The fatal accident occurred on the afternoon of March 10 on Interstate 15.

A Toyota Highlander crashed into an embankment while on northbound Interstate 15 at Bundy Canyon Road. The SUV was crushed. One person died at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Wildomar

#92595


November 13, 2019

4 Injured Crash at Clinton Keith and Hidden Springs Roads

3 Vehicles Involved in Wildomar Accident...


October 29, 2019

Bicyclist Injured in Crash on Berkeley Avenue

Homeless Man Suffers Serious Injuries in Los Angeles Hit and Run Accident...


January 9, 2020

Man Killed in Crash on Towne Avenue

Victim Dies in Claremont Hit and Run Accident; Driver at Large...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.